AIM vs MSFT: Which Stock is Better?
Side-by-side comparison of Aim Immunotech Inc and Microsoft Corp in 2026
AIM
Aim Immunotech Inc
$0.69
MSFT
Microsoft Corp
$397.23
Key Metrics Comparison
| Metric | AIM | MSFT | Winner |
|---|---|---|---|
| Market Cap | $2.79M | N/A | AIM |
| P/E Ratio | N/A | 36.30 | MSFT |
| EPS (TTM) | $N/A | $13.70 | MSFT |
| Revenue Growth | -0.3% | 14.9% | MSFT |
| Gross Margin | 15.2% | 68.8% | MSFT |
Analyze AIM
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AIM or MSFT a better investment?
Comparing AIM and MSFT: Aim Immunotech Inc has a market cap of $2.79M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AIM and MSFT?
AIM (Aim Immunotech Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AIM or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AIM or MSFT?
MSFT has higher revenue growth at 14.9% vs -0.3% for AIM.
Which company is more profitable: AIM or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 15.2% for AIM.
Which is the larger company: AIM or MSFT?
Aim Immunotech Inc (AIM) is larger with a market cap of $2.79M compared to N/A for MSFT.
Should I buy AIM or MSFT in 2026?
Both AIM and MSFT have investment merit. AIM trades at $0.69 while MSFT trades at $397.23. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AIM and MSFT stock?
Key differences: Market Cap ($2.79M vs N/A), P/E Ratio (N/A vs 36.3x), Revenue Growth (-0.3% vs 14.9%), Gross Margin (15.2% vs 68.8%).